Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600)-mutant melanoma: First data of the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA)

Richtig, Erika and Gutzmer, Ralf and Loquai, Carmen and Utikal, Jochen and Hoeller, Christoph and Stadler, Rudolf and Forschner, Andrea and Hassel, Jessica Cecile and Goeppner, Daniela and Fluck, Michael and Haferkamp, Sebastian and Kaatz, Martin and Welslau, Manfred and Dummer, Reinhard and Von Moos, Roger Anton Fredy and Schmidt, Andrea and Milde, Laura and Michielin, Olivier and Schadendorf, Dirk (2021) Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600)-mutant melanoma: First data of the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA). In: 2021 ASCO Annual Meeting, 4. Juni - 8. Juni 2021, Online.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Poster)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User:	Petra Gürster
Date Deposited:	18 Jan 2023 07:08
Last Modified:	18 Jan 2023 07:08
URI:	https://pred.uni-regensburg.de/id/eprint/47957

Actions (login required)

View Item